SCHEMBL10851904

SCHEMBL10851904

O=C(O)C(=O)Nc1ccc2c(=O)n3c(nc2c1)/C(=C/c1ccccc1)CC3

nearest known ligand 0.59

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.58
▸ KMT2A Q03164 7/20 0.58
▸ NME2 P22392 1/20 0.57
▸ ALOX5 P09917 2/20 0.54
▸ RAB9A P51151 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ BLM P54132 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10851910 1.00 MEN1 (0.58) MEN1KMT2ANME2ALOX5RAB9A
SCHEMBL10851536 0.94 NME2 (0.65) MEN1KMT2ANME2
SCHEMBL10851546 0.94 NME2 (0.65) MEN1KMT2ANME2
SCHEMBL10853279 0.93 ALOX5 (0.52) MEN1KMT2ANME2ALOX5RAB9A
SCHEMBL10853295 0.93 ALOX5 (0.52) MEN1KMT2ANME2ALOX5RAB9A
SCHEMBL10849487 0.92 KMT2A (0.59) MEN1KMT2ANME2RAB9AKDM4E
SCHEMBL10849496 0.92 KMT2A (0.59) MEN1KMT2ANME2RAB9AKDM4E
SCHEMBL10851419 0.92 MEN1 (0.54) MEN1KMT2ANME2ALOX5RAB9A
SCHEMBL10851437 0.92 MEN1 (0.54) MEN1KMT2ANME2ALOX5RAB9A
SCHEMBL10857176 0.92 MEN1 (0.54) MEN1KMT2ANME2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4579847-A Amino derivatives of benzylidene-pyrrolo[2,1-b]quinazolines useful for treating conditions of allergic origin FARMITALIA CARLO ERBA S.P.A. (IT) 1986-04-01 — — US claimed
US-4579847-A Amino derivatives of benzylidene-pyrrolo[2,1-b]quinazolines useful for treating conditions of allergic origin FARMITALIA CARLO ERBA S.P.A. (IT) 1986-04-01 — — US disclosed
Send feedback